ANI Pharmaceuticals ANIP
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q3 | 91.60 | 506 | 5.65 | 27 | 1.93 | 1,408 |
| 2025Q2 | 65.25 | 437 | 2.00 | 9 | 0.65 | 1,343 |
| 2025Q1 | 66.95 | 419 | 3.81 | 16 | 1.22 | 1,292 |
| 2024Q4 | 55.28 | 404 | -2.54 | -10 | -0.80 | 1,284 |
| 2024Q3 | 59.66 | 406 | -5.61 | -24 | -2.19 | 1,287 |
| 2024Q2 | 63.68 | 456 | -0.50 | -2 | -0.25 | 921 |
| 2024Q1 | 69.13 | 452 | 4.12 | 18 | 2.00 | 915 |
| 2023Q4 | 55.14 | 433 | 0.27 | 1 | 0.13 | 904 |
| 2023Q3 | 58.06 | 430 | 2.37 | 10 | 1.14 | 890 |
| 2023Q2 | 53.83 | 410 | 1.72 | 6 | 0.77 | 859 |
| 2023Q1 | 39.72 | 315 | 0.46 | 1 | 0.19 | 765 |
| 2022Q4 | 40.23 | 314 | -1.36 | -4 | -0.57 | 760 |
| 2022Q3 | 32.14 | 312 | -2.76 | -9 | -1.15 | 739 |
| 2022Q2 | 29.67 | 312 | -4.71 | -15 | -1.99 | 751 |
| 2022Q1 | 28.11 | 321 | -6.15 | -20 | -2.65 | 745 |
| 2021Q4 | 46.08 | 334 | -9.19 | -24 | -3.89 | 772 |
| 2021Q3 | 32.82 | 191 | -2.32 | -4 | -0.94 | 470 |
| 2021Q2 | 35.05 | 192 | -7.13 | -14 | -2.99 | 480 |
| 2021Q1 | 36.14 | 204 | 0.04 | 0 | 0.02 | 464 |
| 2020Q4 | 29.04 | 196 | -1.86 | -4 | -0.79 | 461 |